Nurr1/RXR targeting program (Inventiva)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNurr1/RXR targeting program (Inventiva)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor modulatorsNuclear receptor subfamily 4 group A member 2 modulators
TargetsNuclear receptor subfamily 4 group A member 2Retinoid X receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInventiva SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInventiva SA
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A